A Personnel Problem: We Need More Antimicrobial Researchers, Infectious Disease Clinicians
A decreasing number of researchers and open positions for infectious disease clinicians and limited residency matches are underlying issues that should be addressed to meet the needs around antimicrobial development and clinical care. Amesh Adalja, MD, FIDSA, discusses some of the challenges behind it.
Vanishing Workforce: An Antimicrobial Resistance Threat
This month, world leaders will gather at the UN General Assembly to address the looming threat of antimicrobial resistance (AMR). They will discuss antimicrobial access, governance, coordination, and many other critical aspects of the fight against AMR. Yet there’s one critical component to any successful outcome that is overlooked and underfunded: the dwindling antimicrobial research […]
Drug-resistant germs will kill millions more people in coming decades, researchers warn
Since the dawn of the antibiotic age, opportunistic pathogens have evolved defenses faster than humans can develop drugs to combat them. At the same time, humans have unwittingly given the bugs an advantage through the overuse of antibiotics, allowing pathogens that survive their exposure to pass on their resistant traits.
New WHO guidance to support manufacturers to reduce AMR risk
The recommendations offered in the guidance is applicable across different areas of manufacturing, from active pharmaceutical ingredients (APIs), through to formulation and packaging.
What Happens When the Last AMR Researcher Turns Off the Lights in the Lab?
Much of modern medicine is possible because of antibiotics. Orthopedic surgeries, caesarean deliveries, and heart and kidney transplants are made safer by antibiotics. Patients who are immunocompromised rely on antibiotics to avoid devastating infections, and those with uncomplicated cystitis, pneumonia and cellulitis feel better after a single course of these amazing products.
UK’s NHS to require companies to meet responsible antibiotic manufacturing standard
The United Kingdom’s National Health Service (NHS) announced yesterday that pharmaceutical companies applying for a contract through its antibiotic subscription model will have to prove they are meeting responsible antibiotic manufacturing standards. The first-of-its kind NHS Antimicrobial Product Subscription Model pays companies a fixed annual fee for antibiotics based on their value to the NHS […]
Antibiotic innovation is ailing. ‘Brain drain’ may kill it
In today’s labor market, good help is hard to find. For companies developing antibiotics, it’s becoming nearly impossible.
Belgium Developing New Class of Antibiotics, But Incentives and Market Support Needed

Europe’s pipeline of new antibiotics to tackle the growing antimicrobial resistance (AMR) crisis remains inadequate. Belgium is developing a new antibiotic class, but success depends on securing vital support and incentives. A recent report by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) reveals that between 2017 and 2023, only ten gained approval, with […]
AMR Industry Alliance calls for ‘bold, coordinated’ action on antimicrobial resistance
The AMR Industry Alliance this week issued a “call-to-action” in advance of the United Nations (UN) High-Level Meeting on AMR (antimicrobial resistance) in September.
Site in India Receives Responsible Antibiotic Manufacturing Certification
Pharmaceutical company Viatris announced today that its manufacturing site in India has received Minimized Risk of Antimicrobial Resistance (AMR) certification.